Four Thought Financial Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Four Thought Financial Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $16,248 - $17,880	-18 Reduced 2.55%	688 $662 Million
Q4 2023 Feb 06, 2024	SELL	$775.18 - $881.7 $9,302 - $10,580	-12 Reduced 1.67%	706 $620 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $9,001 - $10,976	-13 Reduced 1.78%	718 $591 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $37,101 - $44,008	-53 Reduced 6.76%	731 $525 Million
Q1 2023 May 04, 2023	SELL	$680.49 - $826.97 $8,165 - $9,923	-12 Reduced 1.51%	784 $644 Million
Q4 2022 Feb 07, 2023	BUY	$705.89 - $766.39 $561,888 - $610,046	796 New	796 $574 Million

1,492

85.8M

908K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $88.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Four Thought Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Four Thought Financial Partners, LLC with notifications on news.